No abstract available
Publication types
-
Comment
-
Editorial
-
Introductory Journal Article
MeSH terms
-
Animals
-
B-Lymphocytes / drug effects*
-
B-Lymphocytes / immunology
-
Chemokine CXCL13 / cerebrospinal fluid
-
Disability Evaluation
-
Humans
-
Immunoglobulin M / biosynthesis
-
Immunologic Factors / therapeutic use*
-
Multiple Sclerosis, Chronic Progressive / diagnosis
-
Multiple Sclerosis, Chronic Progressive / drug therapy*
-
Multiple Sclerosis, Chronic Progressive / genetics
-
Multiple Sclerosis, Chronic Progressive / immunology
-
Multiple Sclerosis, Relapsing-Remitting / diagnosis
-
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
-
Multiple Sclerosis, Relapsing-Remitting / genetics
-
Multiple Sclerosis, Relapsing-Remitting / immunology
-
Oligoclonal Bands / cerebrospinal fluid
-
Polymorphism, Genetic
-
Prognosis
-
Receptor, Cannabinoid, CB1 / agonists*
-
Receptor, Cannabinoid, CB1 / genetics
-
Severity of Illness Index
Substances
-
CXCL13 protein, human
-
Chemokine CXCL13
-
Immunoglobulin M
-
Immunologic Factors
-
Oligoclonal Bands
-
Receptor, Cannabinoid, CB1